Read + Share
Amedeo Smart
Independent Medical Education
Chen J, Xu J, Yang J, Zhan Y, et al. alpha‑hederin overcomes hypoxia‑mediated drug resistance in colorectal cancer by inhibiting the AKT/Bcl2 pathway. Int J Oncol 2023;62:33.PMID: 36704835
Email
LinkedIn
Facebook
Twitter
Privacy Policy